Increased plasma levels of the soluble Mer tyrosine kinase receptor in systemic lupus erythematosus relate to disease activity and nephritis

被引:0
|
作者
Jun Wu
Carl Ekman
Andreas Jönsen
Gunnar Sturfelt
Anders A Bengtsson
Anders Gottsäter
Bengt Lindblad
Elisabet Lindqvist
Tore Saxne
Björn Dahlbäck
机构
[1] Skåne University Hospital,Department of Laboratory Medicine, Section of Clinical Chemistry, Lund University, Wallenberg Laboratory
[2] Lund University,Department of Clinical Sciences, Section of Rheumatology
[3] Skåne University Hospital,Department of Clinical Sciences, Vascular Center
[4] Lund University,Department of Laboratory Medicine
[5] Skåne University Hospital,undefined
[6] People's Hospital,undefined
[7] Peking University,undefined
来源
Arthritis Research & Therapy | / 13卷
关键词
Systemic Lupus Erythematosus; Nephritis; Systemic Lupus Erythematosus Patient; Lupus Nephritis; Critical Limb Ischemia;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus
    Petri, Michelle
    Stohl, William
    Chatham, Winn
    McCune, W. Joseph
    Chevrier, Marc
    Ryel, Jeff
    Recta, Virginia
    Zhong, John
    Freimuth, William
    ARTHRITIS AND RHEUMATISM, 2008, 58 (08): : 2453 - 2459
  • [42] Levels of plasma soluble VCAM-1 in systemic lupus erythematosus: A clinical marker for disease activity in renal and hematological involvement
    Pizarro, S
    Riebeling, C
    Ruiz, A
    Jara, L
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 247 - 247
  • [43] Adrenomedullin - a potential disease activity marker and suppressor of nephritis activity in systemic lupus erythematosus
    Mak, A.
    Cheung, B. M. Y.
    Mok, C. C.
    Leung, R.
    Lau, C. S.
    RHEUMATOLOGY, 2006, 45 (10) : 1266 - 1272
  • [44] Soluble erythropoietin receptor levels associate with inflammatory mediators but not with disease activity or cumulative organ damage in patients with systemic lupus erythematosus
    Jones, Heather
    Raymond, Warren
    Eilertsen, Gro
    Nossent, Johannes
    EUROPEAN JOURNAL OF INFLAMMATION, 2018, 16
  • [45] EVALUATION OF SERUM LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTOR AS AN INDICATOR OF DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    AIRO, P
    BRAGA, S
    PRATI, E
    BRUGNONI, D
    BETTINZIOLI, M
    GORLA, R
    CATTANEO, R
    CLINICAL RHEUMATOLOGY, 1992, 11 (01) : 97 - 100
  • [46] Effect of disease activity and corticosteroids on serum levels of soluble endothelial cell protein C receptor in patients with systemic lupus erythematosus
    Koarada, Syuichi
    Tsuneyoshi, Naoko
    Haruta, Yoshio
    Tada, Yoshifumi
    Mitamura, Mio
    Inoue, Hisako
    Ohta, Akihide
    Fukudome, Kenji
    Nagasawa, Kohei
    MODERN RHEUMATOLOGY, 2009, 19 (02) : 173 - 179
  • [47] INCREASED EXPRESSION OF SEMAPHORIN 4A IN SYSTEMIC LUPUS ERYTHEMATOSUS AND ITS ASSOCIATION WITH THE ACTIVITY OF LUPUS NEPHRITIS
    Choi, Y.
    Lee, E. K.
    Kim, K. M.
    Lee, M. S.
    Lee, C. H.
    Chung, C. H.
    Yoo, W. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1235 - 1236
  • [48] Soluble and membranous endothelial protein C receptor in systemic lupus erythematosus patients: Relation to nephritis
    Shaaban, Asmaa A.
    Elkadery, Nadia A.
    El-Shamy, Hebatallah A.
    El-Hilaly, Rana A.
    El-Hefnawy, Nadia G.
    Mohamed, Nesrine A.
    EGYPTIAN RHEUMATOLOGIST, 2019, 41 (01): : 25 - 30
  • [49] Bullous systemic lupus erythematosus associated with increased activity of lupus nephritis: a case report and review of the literature
    Zychowska, Magdalena
    Batycka-Baran, Aleksandra
    Maj, Joanna
    Baran, Wojciech
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2018, 35 (04): : 431 - 433
  • [50] The plasma level of soluble receptor for advanced glycation end products in systemic lupus erythematosus patients and its relation to disease activity
    Abou-Raya, Anna Nashaat
    Kamel, Maher Abdel Nabi
    Sayed, Eman Abdel Ghani
    El-Sharkawy, Ahmed Abdel Hamid
    ALEXANDRIA JOURNAL OF MEDICINE, 2016, 52 (02) : 151 - 157